Paper Details

  1. Home
  2. Paper Details

Recurrent submandibular fistula after Sunitinib treatment in a patient with renal cell carcinoma: a case report.

Author: BereczkiDespina Temistocle, CosarcaAdina, GoluMihai Vlad, OrmenisanAlina, PaşcanuIonela, PetrovanCecilia

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

This case report describes a patient who developed a recurrent submandibular fistula while receiving sunitinib, a medication commonly used to treat renal cell carcinoma. The fistula re-appeared after reinitiating sunitinib treatment, and bone abnormalities were also detected. This case suggests a possible association between sunitinib use and osteonecrosis of the jaw, although further investigation is needed.
Paper Details　
Original Abstract of the Article :
Sunitinib is commonly used in the treatment of patients with renal cell carcinoma and is associated with serious side-effects. We present the first report of a recurrent submandibular fistula in a patient treated with sunitinib. A 68-year-old man was referred to our clinic for a cutaneous fistula si...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419685/

データ提供：米国国立医学図書館（NLM）

Recurrent Submandibular Fistula After Sunitinib Treatment in a Patient with Renal Cell Carcinoma: A Case Report

This case report examines a rare and potentially serious side effect of sunitinib, a commonly used medication for treating renal cell carcinoma. The authors describe a patient who developed a recurrent submandibular fistula after receiving sunitinib treatment, highlighting the importance of recognizing and managing this potentially challenging complication.

Sunitinib-Associated Submandibular Fistula: A Rare but Potentially Serious Side Effect

The report provides a detailed account of a patient's experience with a recurrent submandibular fistula following sunitinib treatment, adding to the growing body of knowledge on the potential side effects of this medication. It underscores the importance of vigilant monitoring and timely management of potential complications in patients receiving sunitinib therapy.

Navigating the Desert of Cancer Treatment

This case report highlights the complex and often unpredictable landscape of cancer treatment, emphasizing the importance of careful monitoring for potential side effects. It's like navigating a vast desert, where unexpected challenges can emerge, requiring quick adaptation and decisive action.

Dr.Camel's Conclusion

This case report serves as a valuable reminder of the potential for unexpected side effects in cancer treatment. It's a reminder that even in the vast and often unforgiving desert of cancer treatment, careful observation and prompt intervention are essential for maximizing patient well-being.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-08-15
Further Info :

Pubmed ID

37577019

DOI: Digital Object Identifier

PMC10419685

Related Literature

Article Analysis
・Side Effects of sunitinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.